bufylline
This page covers all bufylline drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1.
Targets
Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1
Patent intelligence
- bufylline patent landscape — aggregated cliff calendar, attackable patents, originator estates